Effectiveness of Prevnar [pneumococcal 7 valent CRM197 vaccine conjugate] in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2012
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- Sponsors Wyeth
- 30 Jan 2012 Planned end date changed from 1 Dec 2011 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 03 Jun 2011 Additional lead trial center identified and company added as reported by ClinicalTrials.gov.
- 06 Apr 2010 Planned end date (Dec 2011) added as reported by ClinicalTrials.gov.